Search

Your search keyword '"Foschi FG"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Foschi FG" Remove constraint Author: "Foschi FG" Topic medicine.disease Remove constraint Topic: medicine.disease
26 results on '"Foschi FG"'

Search Results

1. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

2. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study

3. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres

4. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma

5. Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group

6. Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study

7. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

8. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study

9. Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study

10. Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience

11. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

12. Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort

13. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice

14. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

15. Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

16. Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma

17. Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials

18. Years of life that could be saved from prevention of hepatocellular carcinoma

19. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study

20. DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS

21. Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review

22. Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients

23. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

24. Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients

25. Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma

26. Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis

Catalog

Books, media, physical & digital resources